Abdelbaset Buhmeida

2.6k total citations
101 papers, 2.0k citations indexed

About

Abdelbaset Buhmeida is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Abdelbaset Buhmeida has authored 101 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 44 papers in Molecular Biology and 40 papers in Cancer Research. Recurrent topics in Abdelbaset Buhmeida's work include Genetic factors in colorectal cancer (32 papers), Cancer Genomics and Diagnostics (16 papers) and Colorectal Cancer Treatments and Studies (10 papers). Abdelbaset Buhmeida is often cited by papers focused on Genetic factors in colorectal cancer (32 papers), Cancer Genomics and Diagnostics (16 papers) and Colorectal Cancer Treatments and Studies (10 papers). Abdelbaset Buhmeida collaborates with scholars based in Saudi Arabia, Finland and Libya. Abdelbaset Buhmeida's co-authors include Yrjö Collan, Seppo Pyrhönen, Karí Syrjänen, Mohammed Al‐Qahtani, Matti Laato, Adel Abuzenadah, Jaudah Al‐Maghrabi, Fathi Abdalla, Riyad Bendardaf and Ashraf Dallol and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Abdelbaset Buhmeida

98 papers receiving 2.0k citations

Peers

Countries citing papers authored by Abdelbaset Buhmeida

Since Specialization

Citations

This map shows the geographic impact of Abdelbaset Buhmeida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdelbaset Buhmeida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdelbaset Buhmeida more than expected).

Fields of papers citing papers by Abdelbaset Buhmeida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdelbaset Buhmeida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdelbaset Buhmeida. The network helps show where Abdelbaset Buhmeida may publish in the future.

Co-authorship network of co-authors of Abdelbaset Buhmeida

This figure shows the co-authorship network connecting the top 25 collaborators of Abdelbaset Buhmeida. A scholar is included among the top collaborators of Abdelbaset Buhmeida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdelbaset Buhmeida. Abdelbaset Buhmeida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Immunohistochemical Prognostic Value of Nuclear and Cytoplasmic Silent Information Regulator 1 Protein Expression in Saudi Patients with Breast Cancer 2025 ·Biomolecules ·(unknown), Alia Aldahlawi, Mourad Assidi, Fatemah Basingab, (unknown), (unknown), (unknown), Jaudah Al‐Maghrabi, Abdelbaset Buhmeida, Kaltoom Al‐Sakkaf	1
2	Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer 2023 ·Oncology Letters ·Maryam H. Al-Zahrani, Mourad Assidi, Peter Natesan Pushparaj, Jaudah Al‐Maghrabi, (unknown), (unknown), Abdelbaset Buhmeida, (unknown)	2
3	Utility of Circulating Cell-Free DNA in Assessing Microsatellite Instability and Loss of Heterozygosity in Breast Cancer Using Human Identification Approach 2022 ·Genes ·(unknown), Safia A. Messaoudi, (unknown), (unknown), Abdullah A. Alsharm, Abdulmajeed F. Alrefaei, (unknown), Muhammad Abu‐Elmagd, Mourad Assidi, Abdelbaset Buhmeida, Ãngel Carracedo, Wassim Y. Almawi	5
4	Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma 2022 ·Polish Journal of Pathology ·Jaudah Al‐Maghrabi, (unknown), (unknown), Mourad Assidi, Abdelbaset Buhmeida, Wafaey Gomaa	2
5	The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach 2022 ·Frontiers in Molecular Biosciences ·Mourad Assidi, Abdelbaset Buhmeida, Maryam H. Al-Zahrani, Jaudah Al‐Maghrabi, Mahmood Rasool, Muhammad Imran Naseer, Heba Alkhatabi, Abdulmajeed F. Alrefaei, (unknown), (unknown), Adel Abuzenadah, Peter Natesan Pushparaj, Muhammad Abu‐Elmagd	4
6	Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises 2021 ·International Journal of Molecular Sciences ·Mourad Assidi, (unknown), Maryam H. Al-Zahrani, (unknown), (unknown), (unknown), Jaudah Al‐Maghrabi, Ashraf Dallol, Abdelbaset Buhmeida, Muhammad Abu‐Elmagd	15
7	Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset 2019 ·Bioinformation ·Najla Kharrat, Mourad Assidi, Muhammad Abu‐Elmagd, Peter Natesan Pushparaj, (unknown), (unknown), Muhammad Imran Naseer, Abdelfatteh El Omri, Safia A. Messaoudi, Abdelbaset Buhmeida, Ahmed Rebaï	13
8	Loss of p27 expression in endometrial carcinoma patients with recurrent tumor is significantly associated with poor survival 2018 ·European Journal of Gynaecological Oncology ·Jaudah Al‐Maghrabi, (unknown), (unknown), Abdelbaset Buhmeida, Adel Abuzenadah, (unknown), Mahmoud Al-Ahwal, Mohamad Nidal Khabaz	4
9	Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH 2018 ·Cancer Investigation ·Abdelbaset Buhmeida, Mourad Assidi, Jaudah Al‐Maghrabi, Ashraf Dallol, (unknown), Mahmoud Al-Ahwal, Adeel Chaudhary, Adel Abuzenadah, Mohammed Al‐Qahtani	6
10	Persistent and Endocrine Disrupting Organic Pollutants: Advancements and Challenges in Analysis, Health Concerns and Clinical Correlates 2016 ·Nature Environment and Pollution Technology ·Muhammad Sajid, Chanbasha Basheer, Kothandaraman Narasimhan, Abdelbaset Buhmeida, Mohammed Al‐Qahtani, Mahmoud S. Al-Ahwal	20
11	Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples 2016 ·Journal of Translational Medicine ·Ashraf Dallol, Abdelbaset Buhmeida, Mahmoud S. Al-Ahwal, Jaudah Al‐Maghrabi, Osama S. Bajouh, Shadi Alkhayyat, (unknown), (unknown), Rola Turki, (unknown), Hani A. Alhadrami, (unknown), (unknown), Mohammed Al‐Qahtani, Adel Abuzenadah	32
12	Frequent methylation of the KLOTHO gene and overexpression of the FGFR4 receptor in invasive ductal carcinoma of the breast 2015 ·Tumor Biology ·Ashraf Dallol, Abdelbaset Buhmeida, Adnan Merdad, Jaudah Al‐Maghrabi, Mamdooh Gari, Muhammad Abu‐Elmagd, (unknown), Mourad Assidi, Adeel Chaudhary, Adel Abuzenadah, Taoufik Nedjadi, (unknown), Shadi Alkhayyat, Mohammed Al‐Qahtani	22
13	Immunoexpression of cyclin D1 in colorectal carcinomas is not correlated with survival outcome 2015 ·Journal of Microscopy and Ultrastructure ·Jaudah Al‐Maghrabi, (unknown), Wafaey Gomaa, Abdelbaset Buhmeida, Mohammed Al‐Qahtani, Mahmoud Al-Ahwal	8
14	The significance of sonic hedgehog immunohistochemical expression in colorectal carcinoma 2015 ·Journal of Microscopy and Ultrastructure ·Jaudah Al‐Maghrabi, (unknown), Wafaey Gomaa, Ahmad Abulaban, Mahmoud Al-Ahwal, Abdelbaset Buhmeida, (unknown)	8
15	Methylation of the Polycomb Group Target Genes Is a Possible Biomarker for Favorable Prognosis in Colorectal Cancer 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Ashraf Dallol, Jaudah Al‐Maghrabi, Abdelbaset Buhmeida, Mamdooh Gari, Adeel Chaudhary, Hans-Juergen Schulten, Adel Abuzenadah, Mahmoud S. Al-Ahwal, (unknown), Mohammed Al‐Qahtani	23
16	Diagnosis delay in Libyan female breast cancer 2012 ·BMC Research Notes ·(unknown), Fathi Abdalla, Abdelbaset Buhmeida, (unknown), Seppo Pyrhönen, Yrjö Collan	111
17	Evaluation of HER-2/neu gene amplification by fluorescence in situ hybridization and immunohistochemistry in saudi female breast cancer. 2010 ·PubMed ·(unknown), (unknown), Abdelbaset Buhmeida, Jaudah Al‐Maghrabi, (unknown), Adeel Chaudhary, Mamdooh Gari, Adel Abuzenadah, (unknown)	7
18	PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma 2009 ·Annals of Oncology ·Abdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, Jukka Laine, Yrjö Collan, Matti Laato, Karí Syrjänen, Seppo Pyrhönen	30
19	Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer 2008 ·Human Pathology ·Adam Elzagheid, Eija Korkeila, Riyad Bendardaf, Abdelbaset Buhmeida, (unknown), Antti Vaheri, Karí Syrjänen, Seppo Pyrhönen, Olli Carpén	81
20	Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma 2008 ·World Journal of Gastroenterology ·Adam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, Yrjö Collan, Karí Syrjänen, Seppo Pyrhönen	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact